Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population

Translational Research

Volumn 154, Issue 2, 2009, Pages 78-89

  Amin, Amit P ^a   Mukhopadhyay, Ekanka ^a   Nathan, Sandeep ^b   Napan, Sirikarn ^a   Kelly, Russell F ^a,b  

^a Jr Hospital of Cook County   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ADVERSE OUTCOME; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DIABETES MELLITUS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; POPULATION; PREDICTION; PRIORITY JOURNAL; REVASCULARIZATION; RISK FACTOR; SCORING SYSTEM; ST SEGMENT ELEVATION; SURVIVAL; URBAN AREA;

EID: 67649845528     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.05.004     Document Type: Article

References (43)

1. Eagle K.A., Kline-Rogers E., Goodman S.G., et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 117 (2004) 73-81
2. Granger C.B., Steg P.G., Peterson E., et al. Medication performance measures and mortality following acute coronary syndromes. Am J Med 118 (2005) 858-865
3. Mehta R.H., Roe M.T., Chen A.Y., et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med 166 (2006) 2027-2034
4. Tricoci P., Peterson E.D., and Roe M.T. Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST-segment elevation myocardial infarction (from the CRUSADE Quality Improvement Initiative). Am J Cardiol 98 (2006) 30Q-35Q
5. Blackburn D.F., Dobson R.T., Blackburn J.L., Wilson T.W., Stang M.R., and Semchuk W.M. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol 21 (2005) 485-488
6. Ho P.M., Magid D.J., Masoudi F.A., McClure D.L., and Rumsfeld J.S. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord 6 (2006) 48
7. Gislason G.H., Rasmussen J.N., Abildstrom S.Z., et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 27 (2006) 1153-1158
8. Rasmussen J.N., Chong A., and Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 297 (2007) 177-186
9. Ho P.M., Spertus J.A., Masoudi F.A., et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 166 (2006) 1842-1847
10. Simpson S.H., Eurich D.T., Majumdar S.R., et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333 (2006) 15
11. Osterberg L., and Blaschke T. Adherence to medication. N Engl J Med 353 (2005) 487-497
12. Howland R.H. Medication adherence. J Psychosoc Nurs Ment Health Serv 45 (2007) 15-19
13. Balkrishnan R., and Jayawant S.S. Medication adherence research in populations: measurement issues and other challenges. Clin Ther 29 (2007) 1180-1183
14. O'Connor P.J. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med 166 (2006) 1802-1804
15. Schmidt A.C., Bramlage P., Lichtenthal A., Eckert M., and Scholze J. Socio-economic status and the therapeutic effectiveness of antihypertensive treatment-the design of the LEO study. Curr Med Res Opin 23 (2007) 1987-1995
16. Wamala S., Merlo J., Bostrom G., Hogstedt C., and Agren G. Socioeconomic disadvantage and primary non-adherence with medication in Sweden. Int J Qual Health Care 19 (2007) 134-140
17. Duru O.K., Vargas R.B., Kermah D., Pan D., and Norris K.C. Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens 20 (2007) 348-353
18. Perkins-Porras L., Whitehead D.L., and Steptoe A. Patients' beliefs about the causes of heart disease: relationships with risk factors, sex and socio-economic status. Eur J Cardiovasc Prev Rehabil 13 (2006) 724-730
19. Mensah G.A., Mokdad A.H., Ford E.S., Greenlund K.J., and Croft J.B. State of disparities in cardiovascular health in the United States. Circulation 111 (2005) 1233-1241
20. Lillie-Blanton M., Maddox T.M., Rushing O., and Mensah G.A. Disparities in cardiac care: rising to the challenge of Healthy People 2010. J Am Coll Cardiol 44 (2004) 503-508
21. Watkins L.O. Perspectives on coronary heart disease in African Americans. Rev Cardiovasc Med 5 (2004) S3-13
22. Cerner Corporation: Health Care Information Technology Systems. Cerner Corporation grand rounds academic newsletter, 2008. Available at: http://www.cerner.com/public/default.asp.
23. Cannon C.P., Battler A., Brindis R.G., et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 38 (2001) 2114-2130
24. Chicago hospital strives to match lab, pharmacy data to prevent medication errors. Clin Resour Manag 145 1 (2000) 153-154
25. Ho P.M., Magid D.J., Shetterly S.M., et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med 168 (2008) 271-276
26. Steiner J.F., Koepsell T.D., Fihn S.D., and Inui T.S. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 26 (1988) 814-823
27. Eagle K.A., Lim M.J., Dabbous O.H., et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291 (2004) 2727-2733
28. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (1959) 719-748
29. Anderson J.R., Cain K.C., and Gelber R.D. Analysis of survival by tumor response. J Clin Oncol 1 (1983) 710-719
30. Normand S.L. Evaluating the optimal timing of angiography: landmark or off the mark?. Circulation 116 (2007) 2656-2657
31. Bradley E.H., Herrin J., Wang Y., et al. Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA 292 (2004) 1563-1572
32. Sonel A.F., Good C.B., Mulgund J., et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation 111 (2005) 1225-1232
33. Mehta R.H., Marks D., Califf R.M., et al. Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction. Am J Med 119 (2006) 70-78
34. Chen M.S., Bhatt D.L., Chew D.P., Moliterno D.J., Ellis S.G., and Topol E.J. Outcomes in African Americans and whites after percutaneous coronary intervention. Am J Med 118 (2005) 1019-1025
35. Ferdinand K.C. Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol 97 (2006) 12A-19A
36. Rothman K.J., and Greenland S. Causation and causal inference in epidemiology. Am J Public Health 95 (2005) S144-S150
37. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300
38. Ho P.M., Masoudi F.A., Peterson E.D., et al. Cardiology management improves secondary prevention measures among patients with coronary artery disease. J Am Coll Cardiol 43 (2004) 1517-1523
39. Chewning B. The healthy adherer and the placebo effect. BMJ 333 (2006) 18-19
40. Christensen D.B., Williams B., Goldberg H.I., Martin D.P., Engelberg R., and LoGerfo J.P. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 35 (1997) 1164-1170
41. Lau H.S., de B.A., Beuning K.S., and Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50 (1997) 619-625
42. Steiner J.F., and Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50 (1997) 105-116
43. Tao L.S., Hart P., Edwards E., Evans A.T., Whitaker E., and Smith P. Treatment of difficult-to-control blood pressure in a multidisciplinary clinic at a public hospital. J Natl Med Assoc 95 (2003) 263-269